References
- Rapoport J L. The neurobiology of obsessive-compulsive disorder. JAMA 1988; 269: 2888–2890
- Insel T R. New pharmacological approaches to obsessive compulsive disorder. Journal of Clinical Psychiatry 1990; 51(suppl)47–51
- Judd F K, Chua P, Lynch C, Norman T. Fenfluramine augmentation of clomipramine treatment of obsessive-compulsive disorder. Australian and New Zealand Journal of Psychiatry 1991; 25: 412–414
- Markovitz P J, Stagno S J, Calabrese J R. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. American Journal of Psychiatry 1990; 147: 798–800
- Jenike M A, Baer L, Buttolph L. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. Journal of Clinical Psychiatry 1991; 52: 13–14
- Eison A S, Temple D L. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. American Journal of Medicine 1986; 80(3B)1–9